Study on the minimum effective dose of sufentanil for tracheal intubation in children

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400080170

Enrollment

Unknown

Registered

2024-01-22

Start date

2023-06-01

Completion date

Unknown

Last updated

2024-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Experimental group:ED50%: sufentanil 0.5ug/kg, the dosage of sufentanil for the next child is determined based on the comparison of hemodynamic changes within 5 minutes after intubation with a baselin

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Age 0-18 years old, elective surgery requires endotracheal intubation, general anesthesia, ASA grade I-II

Exclusion criteria

Exclusion criteria: Airway hyperactivity disease, gastroesophageal reflux, difficult airway, obesity, congenital heart disease, hereditary metabolic disease, abnormal liver and kidney function, and family rejection

Design outcomes

Primary

Measure	Time frame
50% minimum effective concentration;90% minimum effective concentration;	—

Secondary

Measure	Time frame
Success rate;complication;	—

Countries

China

Contacts

Public ContactShengfen Tu

Children's Hospital of Chongqing Medical University

519194496@qq.com+86 139 8341 6114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026